Profusa, Inc (PFSA): Enterprise Value to EBITDA Ratio
The share price of Profusa Inc (PFSA) visualized below demonstrates an EV/EBITDA of 0.00. Biosensor production capacities are functioning without disruption, strictly adhering to the development schedule. However, export restrictions and component shortages are hindering expansion into emerging markets. Business stability is ensured by a combination of proprietary sterile laboratories in the US and the engagement of external contractors for final device assembly.
Comprehensive metric breakdowns and analytics for profusa.com (PFSA)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
PFSA - Net Financial Result|Projected Future Earnings Profusa Inc|PFSA - Price to Earnings Ratio|Forward P/E Multiple Profusa Inc|PFSA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc|PFSA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Profusa|PFSA - Earnings per share for the trailing year|Quarterly EPS earnings growth profusa.com|PFSA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Profusa Inc
Analysis of all company metrics:Profusa, Inc. PFSA
This indicator compares the total enterprise value with its operating profit before depreciation and amortization, allowing for an assessment of the real value of assets regardless of debt load and tax regime. For Profusa Inc (PFSA), which is protected by DARPA government grants, the EV/EBITDA valuation multiple serves as a filter that separates the fundamental value of biosensor developments from market noise and inflationary risks.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CUTR (cutera.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|NARI: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|RSLS - Company Value to EBITDA|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
